Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
424.00
0.00 (0.00%)
At close: Jan 13, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $371.17 billion as of January 16, 2026. Its market cap has increased by 65.80% in one year.
Market Cap
371.17B
Enterprise Value
404.78B
Revenue
79.83B
Ranking
n/a
PE Ratio
31.31
Stock Price
$424.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 371.17B, an increase of 4,137.70%. That is a compound annual growth rate of 11.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 371.17B | 4.73% |
| Dec 30, 2025 | 354.42B | 56.67% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |